AT317211B - Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten und von deren Salzen - Google Patents
Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten und von deren SalzenInfo
- Publication number
- AT317211B AT317211B AT272373A AT272373A AT317211B AT 317211 B AT317211 B AT 317211B AT 272373 A AT272373 A AT 272373A AT 272373 A AT272373 A AT 272373A AT 317211 B AT317211 B AT 317211B
- Authority
- AT
- Austria
- Prior art keywords
- azapurin
- derivatives
- salts
- preparation
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5955270 | 1970-12-15 | ||
GB5955670 | 1970-12-15 | ||
GB4975671A GB1338235A (en) | 1970-12-15 | 1971-10-26 | Azapurinones |
GB5345771 | 1971-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AT317211B true AT317211B (de) | 1974-08-26 |
Family
ID=27449009
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT272373A AT317211B (de) | 1970-12-15 | 1971-12-15 | Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten und von deren Salzen |
AT1075671A AT315838B (de) | 1970-12-15 | 1971-12-15 | Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten |
AT272473A AT315839B (de) | 1970-12-15 | 1971-12-15 | Verfahren zur Herstellung von pharmazeutisch zulässigen Salzen von neuen 8-Azapurin-6-on-derivaten |
AT272273A AT319235B (de) | 1970-12-15 | 1971-12-15 | Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT1075671A AT315838B (de) | 1970-12-15 | 1971-12-15 | Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten |
AT272473A AT315839B (de) | 1970-12-15 | 1971-12-15 | Verfahren zur Herstellung von pharmazeutisch zulässigen Salzen von neuen 8-Azapurin-6-on-derivaten |
AT272273A AT319235B (de) | 1970-12-15 | 1971-12-15 | Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten |
Country Status (25)
Country | Link |
---|---|
US (1) | US3987160A (de) |
JP (1) | JPS5310599B1 (de) |
AR (4) | AR192602A1 (de) |
AT (4) | AT317211B (de) |
AU (1) | AU458277B2 (de) |
BE (1) | BE776683A (de) |
BG (3) | BG20806A3 (de) |
CH (5) | CH552610A (de) |
DD (1) | DD95007A5 (de) |
DE (1) | DE2162096A1 (de) |
DK (1) | DK141249B (de) |
FI (1) | FI53457C (de) |
FR (1) | FR2118078B1 (de) |
GB (1) | GB1338235A (de) |
HK (1) | HK42177A (de) |
HU (1) | HU165079B (de) |
IE (1) | IE35897B1 (de) |
IL (1) | IL38364A (de) |
IS (1) | IS1099B6 (de) |
LU (1) | LU64457A1 (de) |
NL (1) | NL174943C (de) |
NO (1) | NO134257C (de) |
OA (1) | OA03930A (de) |
SE (1) | SE393381B (de) |
ZM (1) | ZM18971A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1493685A (en) * | 1970-12-15 | 1977-11-30 | May & Baker Ltd | 8-azapurinones |
BE792648A (fr) * | 1971-12-13 | 1973-06-12 | May & Baker Ltd | Derives de l'isoquinoleine |
FR2406638A1 (fr) * | 1977-10-21 | 1979-05-18 | May & Baker Ltd | Nouvelles aza-8 purinones-6, leur preparation et les compositions pharmaceutiques les contenant |
EP0007727B1 (de) * | 1978-07-24 | 1983-11-30 | Beecham Group Plc | Benzopyranotriazole, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende pharmazeutische Zusammensetzung |
JPS60226887A (ja) * | 1984-04-25 | 1985-11-12 | Dai Ichi Seiyaku Co Ltd | トリアゾロピリミジン誘導体 |
CA1303037C (en) * | 1987-02-02 | 1992-06-09 | Smith Kline & French Laboratories Limited | Purinone derivatives as bronchodilators vasodilators and anti-allergic agents |
US5204353A (en) * | 1987-04-07 | 1993-04-20 | Ciba-Geigy Corporation | 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith |
DE3873812D1 (de) * | 1987-04-07 | 1992-09-24 | Ciba Geigy Ag | 3h-1,2,3-triazolo(4,5-d)pyrimidine. |
FR2618073B1 (fr) * | 1987-07-16 | 1990-09-07 | Pf Medicament | Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation |
GB8817651D0 (en) * | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
DE4211239C2 (de) * | 1992-04-03 | 1995-11-16 | Max Planck Gesellschaft | Arzneimittel gegen Herz-Kreislauf-Erkrankungen |
US5734053A (en) * | 1992-06-26 | 1998-03-31 | Pfizer Inc | Purinone antianginal agents |
GB9213623D0 (en) * | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
GB9311920D0 (en) | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
US20080045573A1 (en) * | 1993-09-20 | 2008-02-21 | Bova David J | Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia |
US6080428A (en) * | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US6676967B1 (en) * | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6129930A (en) * | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
GB9404485D0 (en) * | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
DE19881732D2 (de) | 1997-11-12 | 2000-08-24 | Bayer Ag | 2-Phenyl-substituierte Imidazotriazinone als Phoshodiesterase Inhibitoren |
DE19838705A1 (de) * | 1998-08-26 | 2000-03-02 | Bayer Ag | Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one |
IT1318674B1 (it) * | 2000-08-08 | 2003-08-27 | Nicox Sa | Faramaci per l'incontinenza. |
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2328910B1 (de) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Für die behandlung von gastrointestinalen erkrankungen, entzündungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA3100941C (en) | 2011-03-01 | 2024-03-05 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
EP2968439A2 (de) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Zusammensetzungen zur behandlung von magen-darm-störungen |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
KR102456567B1 (ko) | 2013-08-09 | 2022-10-19 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
RU2019121646A (ru) | 2016-12-14 | 2021-01-15 | Респира Терапьютикс, Инк. | Способы и композиции для лечения легочной гипертензии и других заболеваний легких |
MA54825A (fr) | 2019-01-24 | 2021-12-01 | Prometheus Biosciences Inc | Modulateurs de gpr35 |
EP3972599A1 (de) | 2019-05-21 | 2022-03-30 | Ardelyx, Inc. | Kombination zur senkung des serum-phosphatspiegels bei einem patienten |
WO2022020617A1 (en) * | 2020-07-23 | 2022-01-27 | Prometheus Biosciences, Inc. | Therapeutic agents targeting gpr35 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2407204A (en) * | 1944-07-22 | 1946-09-03 | American Cyanamid Co | Triazolo (d) pyrimidines and methods of preparing the same |
US2993039A (en) * | 1959-11-06 | 1961-07-18 | Upjohn Co | Preparing nu-glycosides of aldose and ketose sugars |
-
1971
- 1971-10-26 GB GB4975671A patent/GB1338235A/en not_active Expired
- 1971-12-06 DK DK596371AA patent/DK141249B/da not_active IP Right Cessation
- 1971-12-14 IE IE1583/71A patent/IE35897B1/xx unknown
- 1971-12-14 CH CH222574A patent/CH552610A/fr not_active IP Right Cessation
- 1971-12-14 SE SE7116090A patent/SE393381B/xx unknown
- 1971-12-14 BE BE776683A patent/BE776683A/xx not_active IP Right Cessation
- 1971-12-14 AU AU36867/71A patent/AU458277B2/en not_active Expired
- 1971-12-14 NL NLAANVRAGE7117142,A patent/NL174943C/xx not_active IP Right Cessation
- 1971-12-14 JP JP10078571A patent/JPS5310599B1/ja active Pending
- 1971-12-14 NO NO4614/71A patent/NO134257C/no unknown
- 1971-12-14 LU LU64457D patent/LU64457A1/xx unknown
- 1971-12-14 IL IL38364A patent/IL38364A/xx unknown
- 1971-12-14 IS IS2047A patent/IS1099B6/is unknown
- 1971-12-14 ZM ZM189/71A patent/ZM18971A1/xx unknown
- 1971-12-14 CH CH1823271A patent/CH555351A/fr not_active IP Right Cessation
- 1971-12-14 OA OA54440A patent/OA03930A/xx unknown
- 1971-12-14 FR FR7144869A patent/FR2118078B1/fr not_active Expired
- 1971-12-14 CH CH1853872A patent/CH546779A/fr not_active IP Right Cessation
- 1971-12-14 HU HUMA2296A patent/HU165079B/hu unknown
- 1971-12-14 CH CH1853772A patent/CH556860A/de not_active IP Right Cessation
- 1971-12-14 DD DD159572A patent/DD95007A5/xx unknown
- 1971-12-14 FI FI3560/71A patent/FI53457C/fi active
- 1971-12-14 DE DE19712162096 patent/DE2162096A1/de active Granted
- 1971-12-14 CH CH1853672A patent/CH550814A/fr not_active IP Right Cessation
- 1971-12-15 AT AT272373A patent/AT317211B/de not_active IP Right Cessation
- 1971-12-15 AT AT1075671A patent/AT315838B/de not_active IP Right Cessation
- 1971-12-15 AT AT272473A patent/AT315839B/de not_active IP Right Cessation
- 1971-12-15 AR AR239632A patent/AR192602A1/es active
- 1971-12-15 AT AT272273A patent/AT319235B/de not_active IP Right Cessation
- 1971-12-15 BG BG20379A patent/BG20806A3/xx unknown
- 1971-12-15 BG BG19250A patent/BG20805A3/xx unknown
- 1971-12-15 BG BG20380A patent/BG20807A3/xx unknown
-
1972
- 1972-12-06 AR AR245510A patent/AR192689A1/es active
- 1972-12-06 AR AR245509A patent/AR199468A1/es active
- 1972-12-06 AR AR245508A patent/AR199467A1/es active
-
1973
- 1973-05-29 US US05/364,425 patent/US3987160A/en not_active Expired - Lifetime
-
1977
- 1977-08-11 HK HK421/77A patent/HK42177A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT317211B (de) | Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten und von deren Salzen | |
AT318615B (de) | Verfahren zur Herstellung von neuen arylsubstituierten Piperazinylalkylchinazolon-(4)-derivaten und deren Salzen | |
AT314540B (de) | Verfahren zur Herstellung von neuen 4-Amino-6-aryl- bzw. 6-heteroaryl-pyrimidinen und von deren Salzen | |
AT302344B (de) | Verfahren zur Herstellung von neuen &beta-Aryl-2-aminoalkoxy-styrolen und deren Salzen | |
AT310174B (de) | Verfahren zur Herstellung von neuen Azepin-Derivaten und deren Säureadditionssalzen | |
AT315858B (de) | Verfahren zur Herstellung von neuen Triazolobenzodiazepinderivaten sowie von deren Salzen | |
AT319208B (de) | Verfahren zur Herstellung von neuen 3-Methylamino-2,4,6,-trijodbenzolverbindungen und deren Salzen | |
AT309463B (de) | Verfahren zur Herstellung von neuen Dialkylxanthinderivaten und deren Salzen | |
ATA993673A (de) | Verfahren zur herstellung von neuen alfa-aminoacylcephalosporinathern und deren salzen | |
AT310182B (de) | Verfahren zur Herstellung von neuen Azepin-Derivaten und deren Säureadditionssalzen | |
AT308123B (de) | Verfahren zur Herstellung von neuen Thienobenzothiazepinderivaten und von deren Säureadditionssalzen | |
AT317901B (de) | Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten und deren Säureadditionssalzen | |
AT321265B (de) | Verfahren zur Herstellung von neuen Benzobicycloalkanaminen und deren Säureadditionssalzen | |
AT296252B (de) | Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten und deren Säureadditionssalzen | |
AT310156B (de) | Verfahren zur Herstellung von neuen Thienyl-imidazolyl-fettsäurederivaten und deren Salzen | |
CH554344A (de) | Verfahren zur herstellung von 5-phenylbenzomorphanderivaten und deren salzen. | |
AT329058B (de) | Verfahren zur herstellung von neuen aminoimidazoloisochinolinderivaten und deren salzen | |
AT310720B (de) | Verfahren zur Herstellung von neuen substituierten o-Anilinophenylacethydroxamsäuren und deren Salzen | |
AT307385B (de) | Verfahren zur Herstellung von neuen 1-Acylaminoalkylphenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen | |
AT294845B (de) | Verfahren zur Herstellung von neuen Nitrofuryl-aminoalkoxy-pyrimidinen und deren Salzen | |
AT303034B (de) | Verfahren zur Herstellung von neuen Imidazolinderivaten und von deren Säureadditionssalzen | |
AT307640B (de) | Verfahren zur Herstellung von neuen 17-Aza-steroiden und deren Salzen | |
AT294094B (de) | Verfahren zur Herstellung von neuen Cycloalkanochinolonderivaten und deren Salzen | |
AT305250B (de) | Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-1-hydroxy-2-(3-aryl-3-hydroxypropyl)-aminoäthanen und von deren Säureadditionssalzen | |
AT308752B (de) | Verfahren zur Herstellung von neuen Cycloalkanochinolonderivaten und deren Salzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |